This resolution officially designates July 15, 2026, as Glioblastoma Awareness Day . It highlights that glioblastoma is the most common, aggressive, and deadly malignant brain tumor, with a grim 5-year survival rate of only 7 percent and a median survival of 8 months. The disease profoundly impacts cognitive ability and quality of life, affecting thousands of individuals in the United States annually. The resolution encourages increased public awareness of glioblastoma and honors individuals who have died from or are currently living with the disease. It supports efforts to develop better treatments, improve long-term prognoses, and enhance the quality of life for patients. Furthermore, it recognizes the importance of molecular biomarker testing and urges a collaborative approach to brain tumor research among governmental, private, and nonprofit organizations, including continued investments in initiatives like the Glioblastoma Therapeutics Network .